Immunoproteomics approach for the discovery of antigens applied to the diagnosis of canine visceral leishmaniasis.
暂无分享,去创建一个
A. B. Reis | D. Menezes-Souza | D. Pimenta | B. M. Roatt | A. M. Carvalho | M. C. Duarte | E. Coelho | Larissa Chaves Freire | N. C. Galvani | R. A. M. de Ávila | Gabriel P. Luiz | A. Fernandes | E. Neto | Scarleth Silva Costa | Lucas Magno Oliveira Santos | Ana Luiza Filizzola Tedeschi | Naianda Rezende Ribeiro | Mariana Helena Rodrigues Queiroz | Maria Eduarda B S de Oliveira | Bryan Victor Serafim Brigido | D. C. Pimenta
[1] D. Menezes-Souza,et al. Development of an immunogen containing CD4+/CD8+ T-cell epitopes for the prophylaxis of tegumentary leishmaniasis , 2022, Applied Microbiology and Biotechnology.
[2] D. Menezes-Souza,et al. Development of a chimeric protein based on a proteomic approach for the serological diagnosis of human tegumentary leishmaniasis , 2021, Applied Microbiology and Biotechnology.
[3] D. Menezes-Souza,et al. Evaluation of the protective efficacy of a Leishmania protein associated with distinct adjuvants against visceral leishmaniasis and in vitro immunogenicity in human cells , 2020, Parasitology Research.
[4] Grasiele S. V. Tavares,et al. An immunoproteomics approach to identify Leishmania infantum proteins to be applied for the diagnosis of visceral leishmaniasis and human immunodeficiency virus co-infection , 2020, Parasitology.
[5] N. Santarém,et al. Challenges in the serological evaluation of dogs clinically suspect for canine leishmaniasis , 2020, Scientific Reports.
[6] B. M. Roatt,et al. Immunodiagnosis of human and canine visceral leishmaniasis using recombinant Leishmania infantum Prohibitin protein and a synthetic peptide containing its conformational B-cell epitope. , 2019, Journal of immunological methods.
[7] D. Menezes-Souza,et al. A biomarker for tegumentary and visceral leishmaniasis based on a recombinant Leishmania hypothetical protein. , 2019, Immunobiology.
[8] F. Galvis-Ovallos,et al. Use of miltefosine to treat canine visceral leishmaniasis caused by Leishmania infantum in Brazil , 2019, Parasites & Vectors.
[9] Grant D. Brown,et al. Comorbid infections induce progression of visceral leishmaniasis , 2019, Parasites & Vectors.
[10] A. B. Reis,et al. Comparative analysis of real-time PCR assays in the detection of canine visceral leishmaniasis , 2018, Parasitology Research.
[11] D. Menezes-Souza,et al. Immunogenomic screening approach to identify new antigens for the serological diagnosis of chronic Chagas’ disease , 2018, Applied Microbiology and Biotechnology.
[12] S. Sundar,et al. Understanding Leishmania parasites through proteomics and implications for the clinic , 2018, Expert review of proteomics.
[13] S. Carver,et al. Association between canine leishmaniosis and Ehrlichia canis co-infection: a prospective case-control study , 2018, Parasites & Vectors.
[14] F. Dantas-Torres,et al. Canine visceral leishmaniasis: Diagnosis and management of the reservoir living among us , 2018, PLoS neglected tropical diseases.
[15] C. Petersen,et al. Novel Areas for Prevention and Control of Canine Leishmaniosis. , 2017, Trends in parasitology.
[16] C. Petersen,et al. Diagnostic Challenges in the Era of Canine Leishmania infantum Vaccines. , 2017, Trends in parasitology.
[17] D. Menezes-Souza,et al. Probing the efficacy of a heterologous Leishmania/L. Viannia braziliensis recombinant enolase as a candidate vaccine to restrict the development of L. infantum in BALB/c mice. , 2017, Acta tropica.
[18] D. Menezes-Souza,et al. A vaccine composed of a hypothetical protein and the eukaryotic initiation factor 5a from Leishmania braziliensis cross-protection against Leishmania amazonensis infection. , 2017, Immunobiology.
[19] D. Menezes-Souza,et al. Evaluation of a hypothetical protein for serodiagnosis and as a potential marker for post-treatment serological evaluation of tegumentary leishmaniasis patients , 2017, Parasitology Research.
[20] D. Menezes-Souza,et al. A recombinant chimeric protein composed of human and mice‐specific CD4+ and CD8+ T‐cell epitopes protects against visceral leishmaniasis , 2017, Parasite immunology.
[21] D. Menezes-Souza,et al. A vaccine combining two Leishmania braziliensis proteins offers heterologous protection against Leishmania infantum infection. , 2016, Molecular immunology.
[22] S. Sundar,et al. Recent developments and future prospects in the treatment of visceral leishmaniasis , 2016, Therapeutic advances in infectious disease.
[23] D. Menezes-Souza,et al. A new Leishmania-specific hypothetical protein and its non-described specific B cell conformational epitope applied in the serodiagnosis of canine visceral leishmaniasis , 2016, Parasitology Research.
[24] M. O. Rocha,et al. Proteins Selected in Leishmania (Viannia) braziliensis by an Immunoproteomic Approach with Potential Serodiagnosis Applications for Tegumentary Leishmaniasis , 2015, Clinical and Vaccine Immunology.
[25] R. Gazzinelli,et al. Novel Recombinant Multiepitope Proteins for the Diagnosis of Asymptomatic Leishmania infantum-Infected Dogs , 2015, PLoS neglected tropical diseases.
[26] D. Bartholomeu,et al. Linear B-cell epitope mapping of MAPK3 and MAPK4 from Leishmania braziliensis: implications for the serodiagnosis of human and canine leishmaniasis , 2015, Applied Microbiology and Biotechnology.
[27] D. Bartholomeu,et al. Mapping B-Cell Epitopes for the Peroxidoxin of Leishmania (Viannia) braziliensis and Its Potential for the Clinical Diagnosis of Tegumentary and Visceral Leishmaniasis , 2014, PloS one.
[28] D. Menezes-Souza,et al. Identification of Differentially Expressed Proteins from Leishmania amazonensis Associated with the Loss of Virulence of the Parasites , 2014, PLoS neglected tropical diseases.
[29] R. Corrêa-Oliveira,et al. Evaluation of Change in Canine Diagnosis Protocol Adopted by the Visceral Leishmaniasis Control Program in Brazil and a New Proposal for Diagnosis , 2014, PloS one.
[30] O. Courtenay,et al. Heterogeneities in Leishmania infantum Infection: Using Skin Parasite Burdens to Identify Highly Infectious Dogs , 2014, PLoS neglected tropical diseases.
[31] C. Carneiro,et al. Molecular diagnosis of canine visceral leishmaniasis: a comparative study of three methods using skin and spleen from dogs with natural Leishmania infantum infection. , 2013, Veterinary parasitology.
[32] D. P. Lage,et al. Sensitive and Specific Serodiagnosis of Leishmania infantum Infection in Dogs by Using Peptides Selected from Hypothetical Proteins Identified by an Immunoproteomic Approach , 2013, Clinical and Vaccine Immunology.
[33] C. Jaffe,et al. Identification of Babesia species infecting dogs using reverse line blot hybridization for six canine piroplasms, and evaluation of co-infection by other vector-borne pathogens. , 2013, Veterinary parasitology.
[34] J. Cano,et al. Leishmaniasis Worldwide and Global Estimates of Its Incidence , 2012, PloS one.
[35] M. Santoro,et al. Identification of Proteins in Promastigote and Amastigote-like Leishmania Using an Immunoproteomic Approach , 2012, PLoS neglected tropical diseases.
[36] A. Falqueto,et al. Evaluation of a novel chromatographic immunoassay based on Dual-Path Platform technology (DPP® CVL rapid test) for the serodiagnosis of canine visceral leishmaniasis. , 2012, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[37] C. Carneiro,et al. Humoral and cellular immune responses in dogs with inapparent natural Leishmania infantum infection. , 2011, Veterinary journal.
[38] R. Gazzinelli,et al. High-Throughput Analysis of Synthetic Peptides for the Immunodiagnosis of Canine Visceral Leishmaniasis , 2011, PLoS neglected tropical diseases.
[39] M. Boelaert,et al. Control of Visceral Leishmaniasis in Latin America—A Systematic Review , 2010, PLoS neglected tropical diseases.
[40] R. Peeling,et al. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? , 2007, Nature Reviews Microbiology.
[41] Brian White,et al. Comparative genomic analysis of three Leishmania species that cause diverse human disease , 2007, Nature Genetics.
[42] R. Gazzinelli,et al. Comparative Evaluation of Enzyme-Linked Immunosorbent Assays Based on Crude and Recombinant Leishmanial Antigens for Serodiagnosis of Symptomatic and Asymptomatic Leishmania infantum Visceral Infections in Dogs , 2007, Clinical and Vaccine Immunology.
[43] P. Williams,et al. Canine visceral leishmaniasis: Relationships between clinical status, humoral immune response, haematology and Lutzomyia (Lutzomyia) longipalpis infectivity , 2007, The Veterinary Journal.
[44] L. Alves,et al. Canine visceral leishmaniosis: a comparative analysis of the EIE-leishmaniose-visceral-canina-Bio-Manguinhos and the IFI-leishmaniose-visceral-canina-Bio-Manguinhos kits. , 2006, Veterinary parasitology.
[45] G. Capelli,et al. Evaluation of Enzyme-Linked Immunosorbent Assays, an Immunofluorescent-Antibody Test, and Two Rapid Tests (Immunochromatographic-Dipstick and Gel Tests) for Serological Diagnosis of Symptomatic and Asymptomatic Leishmania Infections in Dogs , 2005, Journal of Clinical Microbiology.
[46] F. Pedonese,et al. Evaluation of dot enzyme-linked immunosorbent assay (dot-ELISA) for the serodiagnosis of canine leishmaniosis as compared with indirect immunofluorescence assay. , 1996, Veterinary parasitology.